Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up.

Department of Radiology, Stanford University Medical Center, Stanford, CA 94305, USA.
American Journal of Neuroradiology (Impact Factor: 3.17). 03/2005; 26(3):525-30.
Source: PubMed

ABSTRACT Angioplasty and stent placement have been reported for the treatment of intracranial stenosis. This study was undertaken to assess the efficacy and long-term clinical outcome of angioplasty without stent placement for patients with symptomatic intracranial stenosis.
A retrospective study was done to evaluate 36 patients with 37 symptomatic atherosclerotic intracranial stenosis who underwent primary balloon angioplasty. All patients had symptoms despite medical therapy. Thirty-four patients were available for follow-up ranging from 6 to 128 months. Mean follow-up was 52.9 months.
Mean pretreatment stenosis was 84.2% before angioplasty and 43.3% after angioplasty. The periprocedural death and stroke rate was 8.3% (two deaths and one minor stroke). Two patients had strokes in the territory of angioplasty at 2 and 37 months after angioplasty. The annual stroke rate in the territory appropriate to the site of angioplasty was 3.36%, and for those patients with a residual stenosis of > or =50% it was 4.5%. Patients with iatrogenic dissection (n=11) did not have transient ischemic attacks or strokes after treatment.
Results of long-term follow-up suggest that intracranial angioplasty without stent placement reduces the risk of further stroke in symptomatic patients.

  • [Show abstract] [Hide abstract]
    ABSTRACT: : The use of balloons in the field of neurosurgery is currently an essential part of our clinical practice. The field has evolved over the last 40 years since Serbinenko used balloons to test the feasibility of occluding cervical vessels for intracranial pathologies. Since that time, indications have expanded to include sacrificing cervical and intracranial vessels with detachable balloons, supporting the coil mass in wide-necked aneurysms (balloon remodeling technique), and performing intracranial and cervical angioplasty for atherosclerotic disease, as well as an adjunct to treat arteriovenous malformations. With the rapid expansion of endovascular technologies, it appears that the indications and uses for balloons will continue to expand. In this article, we review the history of balloons, the initial applications, the types of balloons available, and the current applications available for endovascular neurosurgeons. BRT, balloon remodeling techniqueBTO, balloon test occlusionCAS, carotid artery stentingCCF, carotid cavernous fistulasCEA, carotid endarterectomyCPD, cerebral protection deviceDMSO, dimethyl sulfoxideFDA, Food and Drug AdministrationICA, internal carotid arteryMCA, middle cerebral arteryPTA, percutaneous transluminal angioplastySAMMPRIS, Stenting vs Aggressive Medical Management for the Prevention of Recurrent StrokeTBA, transluminal balloon angioplasty.
    Neurosurgery 02/2014; 74 Suppl 1:S163-S190. · 2.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Stroke is a heterogeneous disease caused by a sustained interruption of the blood supply to part of the brain. Prevention and treatment of this disease is of primary importance as it has been estimated to be the second leading cause of death worldwide. Due to the large number of possible origins there is no general strategy for preventive treatment and evidence based recommendations are given. However major causes of stroke can be confined to few vascular districts. More and more evidence is supporting the hypothesis that biomechanical and hemodynamic parameters can be related to catastrophic cerebrovascular events. In this context structural and fluidodynamic computer simulations offer an optimal tool to quantify these predictors. On the other hand the advances in medical imaging allow providing realistic in vivo conditions (such as reliable anatomical geometries and initial mechanical state) for patient specific analysis. This paper reviews the progress and the state of art of numerical simulation used to analyze the early stages and the progression of the disease as well as their potential as tool for risk assessment, for treatment outcome and procedure planning.
    Cardiovascular Engineering and Technology. 12/2013;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Intracranial atherosclerotic disease (ICAD) represents a major cause of stroke and transient ischemic attacks. The prevalence and natural course of ICAD are closely related to race and ethnicity. The best treatment for ICAD is a crucial issue; data from recent trials indicate that aggressive medical management and life style modifications are better than endovascular treatments for prevention of recurrent stroke in high-risk patients with ICAD. Endovascular treatment is still an option for subgroup of patients who are not responded to optimal medical therapy.
    World Journal of Cardiovascular Diseases 06/2014; 4:350-360.